on AIAI Holdings (NASDAQ:AIAI)
MediGuide Launches Longevity Intelligence for Preventive Healthcare
AIAI Holdings Corporation has introduced the Longevity Intelligence Service through its portfolio company, MediGuide. This innovative service blends advanced diagnostics, predictive health intelligence, and physician expertise to offer personalized preventive healthcare solutions. The focus is on early detection and personalized clinical guidance.
Todd Furniss, CEO of AIAI Holdings, emphasized the strategic expansion as a move from Medical Second Opinions to precision healthcare, enhancing MediGuide's market position. CEO Vera Guerreiro of MediGuide highlighted the service's role in helping individuals understand their health proactively, combining biomarker evaluation, lifestyle analysis, and personalized recommendations.
MediGuide's approach involves four integrated layers: Biological Intelligence, Trajectory Intelligence, Intervention Intelligence, and Delivery Intelligence, aimed at providing comprehensive health insights and care pathway recommendations.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AIAI Holdings news